FRATES JAMES M (Chief Financial Officer) received a stock award from AMYLYX PHARMACEUTICALS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 3/9/2026ACC: 0001193125-26-098438
Officer· Chief Financial Officer
Since Jan 2022
+239.97K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
239.97K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+95.99K
Price / share
—
Trade value
—
% of position
58.0%
3/5/2026
165.64K→261.63K
Total
Net shares
+95.99K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/5/2026 | A · Award | +95.99K | — | — | 58.0% | 165.64K | 261.63K |
| Total | +95.99K | $0.00 | ||||||
Derivative Transactions1
Stock Option (right to buy)
Direct
Converts to
Common Stock
143.99K shares
Shares
+143.99K
Strike price
14.10
Held after
143.99K
Exercisable
—
3/5/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Common Stock143.99K shares | 3/5/2026 | A · Award | +143.99K | 14.10 | — | 143.99K |
Non-Derivative Holdings (Post-Transaction)3
Common Stock
IndirectShares owned100K
Common Stock
IndirectShares owned15.46K
Common Stock
IndirectShares owned11.07K
Total
126.53K indirect126.53K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 100K | Indirect |
| Common Stock | 15.46K | Indirect |
| Common Stock | 11.07K | Indirect |
| Total | 126.53K | 126.53K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported